Boehringer Ingelheim International GmbH

Boehringer Ingelheim International GmbH is a leading global research-driven pharmaceutical company headquartered in Ingelheim, Germany. Founded in 1885, it remains one of the world's largest private healthcare organizations, focusing on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing. The company is dedicated to discovering and developing innovative therapies for diseases with high unmet medical needs, including respiratory, cardiovascular, and metabolic conditions. With over 54,000 employees worldwide, Boehringer Ingelheim leverages cutting-edge science and strategic partnerships to improve the health and well-being of both humans and animals across the globe.